Next Article in Journal
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
Next Article in Special Issue
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial
Previous Article in Journal
Efficacy of Thermal Ablation for Small-Size (0–3 cm) versus Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)
Previous Article in Special Issue
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4347; https://doi.org/10.3390/cancers15174347
Action Date Notes Link
article xml file uploaded 31 August 2023 09:11 CEST Original file -
article xml uploaded. 31 August 2023 09:11 CEST Update https://www.mdpi.com/2072-6694/15/17/4347/xml
article pdf uploaded. 31 August 2023 09:11 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4347/pdf
article supplementary file uploaded. 31 August 2023 09:11 CEST - https://www.mdpi.com/2072-6694/15/17/4347#supplementary
article html file updated 31 August 2023 09:12 CEST Original file https://www.mdpi.com/2072-6694/15/17/4347/html
Back to TopTop